𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinicopathological characteristics of p53 overexpression in endometrial cancers

✍ Scribed by Masaki Inoue; Akira Okayama; Masami Fujita; Takayuki Enomoto; Masahiro Sakata; Osamu Tanizawa; Hirotsugu Ueshima


Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
637 KB
Volume
58
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Using immunohistochemical methods, we analyzed the association between nuclear p53 overexpression and various clinicopathological parameters in patients with endometrial cancers. Formalin-fixed and paraffin-embedded tissue sections from I39 cases of endometrial cancer (endometrioid type, 126; serous papillary type, 12; and clear-cell type, I) were stained with anti-p53 monoclonal antibody (MAb) D07. Overexpression of p53 was associated with high malignant potential, including extensive muscular invasion, advanced surgical stage, high histological grade, serous papillary type and a personal history of cancer. Lymph-node metastasis was also related to p53 overexpression with marginal significance. Survival curves determined by the Kaplan-Meier method and univariate analysis showed p53 overexpression to be associated with a poor outcome in endometrial cancer patients. However, multivariate analysis using the stepwise Cox proportional-hazard model showed that whereas lymph-node metastasis, a personal history of cancer and muscular invasion were related to poor survival rates, p53 overexpression was not. Consequently, p53 overexpression itself does not appear to be an independent prognostic factor in endometrial cancer, although a still larger sample of patient material would be required to assess this issue definitively.


πŸ“œ SIMILAR VOLUMES


Clinicopathological variables and p53 ov
✍ Yamamura, Takuya; Matsuzaki, Hiroaki; Suda, Tadashi; Ozasa, Takao; Tsukikawa, Sa πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

Background and Objectives: Precise evaluation of the prognostic factors for hematogenic recurrence after resection for colorectal cancer is important not only for the prediction of patient outcome but also for the determination of adjuvant therapy. The purpose of the current study was to elucidate t

Overexpression of P53 in head and neck c
✍ David L. Watling; Dr. Allen M. Gown; Dr. Marc D. Coltrera πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 766 KB

The putative tumor suppressor gene p53 plays a key role in the regulation of cell proliferation. Functional loss of p53 protein through mutation or viral oncogene-complexing can result in p53 protein overexpression detectable by immunocytochemistry, which in turn has been associated with markers of

Functional analysis of p53 gene and the
✍ Noriaki Sakuragi; Hidemichi Watari; Yasuhiko Ebina; Ritsu Yamamoto; Eric Steiner πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 182 KB πŸ‘ 1 views

## Abstract In addition to the loss of function, mutant p53 can possess a dominant‐negative effect on wild‐type p53 and may also exert gain‐of‐function activity. It is not clear whether the functional status of __p53__ mutation contributes to differences in outcome in endometrial cancer. We collect